Detectable AML cell expression of CDX2 is seen for a large majority of AML patients [35]; the levels are particularly high for patients with normal karyotype whereas the favorable abnormality t(8;21) shows lower levels [39]. Here, CDX2 is linked to acute myeloid leukemia.